°µÍø³Ô¹Ï

$75.6 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$50.6 Million
Fulcrum Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$52.8 Million
Catalyst Biosciences, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$73.8 Million
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$51.7 Million
Milestone Pharmaceuticals Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.5 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$100.9 Million
Cardiff Oncology Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.5 Million
Chiasma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Altimmune, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Harpoon Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 °µÍø³Ô¹Ï. Since 1895. All rights reserved.